• 08/15/2017 12:52 PM | Deleted user

    The First Coast Academy of Nutrition and Dietetics (FCAND) would like to congratulate our 2016-2017 award winners:

    Outstanding Dietitian of the Year: Gina Ulery
    Emerging Dietetic Leader: Dorreta Leung
    Recognized Young Dietitian of the Year: Yemila Lowry

  • 09/27/2016 10:45 AM | Deleted user

    The American Society for Nutrition has an upcoming conference, Advances and Controversies in Clinical Nutrition, in Orlando (December 8-10, 2016). 

    The conference highlights the latest research and best practices in nutrition. Sessions will explore cutting-edge advances in nutrition research, and stimulate discussion on emerging and controversial topics that impact health, wellness, treatment and prevention.

    • Dates: Thursday, December 8 – Saturday, December 10, 2016
    • Location: Rosen Shingle Creek Resort in Orlando, FL
    • Registration will open in early October. Register by October 31, 2016 for the best rates!
    • Abstracts are being submitted now through October 7th.

    ACCN16 is being conducted through a joint providership with the Tufts University School of Medicine. Approximately 16 continuing education credits for registered dietitians/nutritionists, physicians, and nurses will be provided. 

    The website for the conference is:

    For further information please email me at

    Thank you!

    Best Regards,



    Stephanie A. Dunbar, MPH, RD

    American Society for Nutrition

    9211 Corporate Blvd, Suite 300

    Rockville, MD 20850

  • 07/09/2015 11:23 AM | Deleted user

    Congratulations to FCAND for receiving the award for "Most Creative Activities during National Nutrition Month 2015"! A BIG thank you to all the RDN's and students who worked hard on all the First Coast's NNM Events!

    FCAND 2014-2015 National Nutrition Month Scrapbook Submission.ppt-1.pptx

  • 09/12/2014 10:34 AM | Deleted user
    If you need your morning coffee to wake up and several more cups to get through the day, you may worry that your habit isn’t healthy. Although experts say coffee is one of the best beverages you can drink, too much caffeine can have serious side effects.

    Here, find out what the latest research shows and if you should cut back or cut out coffee altogether.

    Coffee is nutrient-dense.

    According to the National Coffee Association, 63 percent of Americans drink coffee every day and with good reason. Coffee packs a ton of nutrients including magnesium, potassium, B vitamins, niacin, and choline.

    It’s also the largest source of antioxidants in our diets, said Dr. Arfa Babaknia, a family medicine physician at Orange Coast Memorial Medical Center in Fountain Valley, Calif.

    What’s more, if you take your coffee with milk, it’s a great way to get vitamin D and calciumundefined especially because so many Americans are deficient in them, said Joan Salge Blake, a spokesperson for the Academy of Nutrition and Dietetics.

    It protects from disease.

    Studies show coffee may decrease the risk for liver, colon, prostate, ovarian and oral cancers, basal cell carcinoma, stroke and heart disease. It may also prevent Parkinson’s disease, Alzheimer's disease and Type 2 diabetes.

    A recent study out of Cornell University found that drinking coffee may even protect the eyes from retinal degeneration as a result of glaucoma, aging and diabetes.

    Although the research is promising, these studies are prospective and only look at 10 or 15 years of a person’s life so it’s not enough evidence to recommend everyone start drinking coffee, Babaknia said.

    Better mood, more energy and weight loss.

    Drinking coffee can also increase energy and improve memory, reaction time and mood. In fact, a study out of the Harvard School of Public Health found that people who drink two to four cups of coffee a day reduce their risk for suicide by 50 percent.

    While coffee burns fat, aids weight loss and can boost your metabolism by as much as 4 percent, this effect is seen more in people who are already thin, Babaknia said.

    A cup of coffee 30 to 60 minutes before exercise may improve your performance in the gym as well.

    Too much of a good thing?

    “Some is good, more may not be better,” Salge Blake said.

    Your daily caffeine intake can add up quickly, especially when 16 ounces at many coffee shops is the norm. Plus, if you drink iced coffee, the portions tend to be large and usually aren’t watered down so a majority of the cup is coffee. Another thing to consider is that if you drink tea, soda, sports drinks, eat chocolate, or take pain relievers, you could be consuming more caffeine than you think.

    Coffee can also decrease iron and calcium absorption, increase heart rate and anxiety, cause gastroesophageal reflux disease (GERD) or make irritable bowel syndrome (IBS) symptoms worse.

    It can also increase blood pressure, but only in people who don’t drink it every day, Babaknia said. People who have Type 2 diabetes should avoid coffee because it elevates blood glucose levels.

    Even if you drink coffee hours before going to bed, even a cup can make it hard to fall asleep or stay asleep. And the next day you end up drinking more coffee to stay alert.

    “It becomes this viscous cycle where it can really have an effect on your sleep,” Salge Blake said.

    Experts agree women who are struggling with infertility, or are undergoing in vitro fertilization (IVF) treatment should avoid coffee. Although it’s unclear if coffee causes miscarriage or preterm birth, pregnant women should limit their total caffeine intake to 200 milligrams a day.

    If you have withdrawal symptoms like headache, fatigue, or irritability, gradually reduce your consumption or switch to decaf.

    The sweet spot seems to be no more than 4 cups or 400 milligrams of coffee a day to get the health benefits and curb your cravings without any side effects. But the right amount really depends on how it makes you feel.

    “As long as coffee doesn’t make you jittery, hyper, give you a headache or cause insomnia, there is no limit,” Babaknia said.


  • 09/11/2014 11:38 AM | Deleted user
    For the third time in about two years, the Food and Drug Administration has approved a new weight-loss pill.

    Contrave got FDA approval Wednesday. The medication is made by Orexigen Therapeutics Inc., San Diego, and will be marketed by Takeda Pharmaceutical of Japan. It joins some older drugs and two newer pills, Qsymia and Belviq, as options to help adults battle their bulges.

    All of the new drugs work by decreasing appetite and all have some side effects and drawbacks, though they differ. None promise massive weight loss.

    "Obesity continues to be a major public health concern," the FDA's Jean-Marc Guettier said in a press release. "When used as directed in combination with a healthy lifestyle that includes a reduced-calorie diet and exercise, Contrave provides another treatment option."

    Like its competitors, Contrave is approved for people who are obese or who are overweight and also have weight-related health problems, such as diabetes.

    Contrave is a combination of two drugs: naltrexone, which is also is used to treat alcohol and drug dependence, and bupropion an antidepressant also used as a smoking cessation treatment.

    It will come with a warning that it might increase suicidal thoughts. Other possible side effects include increases in blood pressure and heart rate, FDA says.

    In trials, patients taking Contrave lost 2% to 4.1% more weight than those taking placebo. Between 36% and 42% lost at least 5% of their body weight.

    In Belviq's studies for the FDA, average losses were 3% to 3.7% over placebo; for Qsymia, average losses were 6.7% to 8.9% over placebo.

    Such weight losses can be meaningful, but they won't happen if consumers rely on pills alone, says Adam Tsai, a Denver internist who chairs the public affair committee of the Obesity Society, a group representing weight loss experts.

    "The ideal candidate for a drug to treat obesity is someone who uses the drug as a tool, along with diet and exercise," says Tsai, who has no ties with drug makers.

    So far, the other new pills have not been big sellers – considering that more than a third of U.S. adults, 78.6 million, are obese, according the federal Centers for Disease Control and Prevention.

    One reason: Insurers have been slow to cover the treatments, which have been priced at upwards of $200 a month. Manufacturers have offered discounts to encourage consumers to try them.

    Patients filled about 138,000 prescriptions for Qsymia in the second quarter of 2014, according to drug maker Vivus Inc.

    Prescription numbers for Belviq were about 110,000 in the same period, according to Arena Pharmaceuticals Inc., which makes the drug. Belviq is marketed by Eisai Co.

    Just 2% of people who are candidates for drug treatment are using a drug now, says Craig Audet, senior vice president for operations at Arena. That's a lot of room for growth, he says, and having a third drug approved just "gets more voices out there" talking about the pharmaceutical options.

    Audet says insurers are increasingly paying for the medications, with 60% of privately insured patients now getting some coverage, up from 30% when Belviq was introduced in 2013.

    In the past, some obesity drugs have been linked to serious heart problems and pulled from the market.

    The makers of Contrave, Belviq and Qsymia have all agreed to conduct long-term heart safety studies and report the results to FDA.


  • 09/04/2014 8:21 PM | Deleted user

    CVS Tobacco BanCVS, the giant drugstore chain that shocked the U.S. public health community and Wall Street with its decision earlier this year to remove tobacco products from its shelves by October, said cigarettes are officially no longer on store shelves a month ahead of schedule.

    The move to remove tobacco products effective yesterday morning coincides with a company decision to also change its corporate name to CVS Health (CVS), from CVS/Caremark Corp. to reflect “its broader health care commitment” and desire to change the future health of Americans.

    When CVS first announced in February that it would end the sale of tobacco products at its stores effective October 1, chief executive officer Larry Merlo said it would cost the company about $2 billion in annual sales, or about 3 percent of company revenues.

    Merlo said in an interview with Forbes that the loss of those sales continues and “will cycle through the next 12 months.” He described the decision to stop selling tobacco as “one of those intangibles” that helps the company win new business and make up for lost sales from cigarettes and related products.

    More info:

  • 09/04/2014 6:48 PM | Deleted user

    The First Coast Academy of Nutrition and Dietetics (FCA), formerly the Jacksonville Dietetic Association (JDA), has a new name - and website! 

    The new website allows members to create an account where they can access member-only content (such as a membership directory) and renew membership online! The site is still under construction, so please check back often for new features.

Subscribe to FCA e-Newsletter!

First Coast Academy of Nutrition & Dietetics

P.O. Box 11964

Jacksonville, FL 32277

Contact us via email

Terms of Service & Privacy Policy

Powered by Wild Apricot Membership Software